Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 7;13(7):1316.
doi: 10.3390/v13071316.

Hepatitis C Virus Subtypes Novel 6g-Related Subtype and 6w Could Be Indigenous in Southern Taiwan with Characteristic Geographic Distribution

Hung-Da Tung  1 , Pei-Lun Lee  1 , Jyh-Jou Chen  1 , Hsing-Tao Kuo  2 , Ming-Jen Sheu  2 , Chun-Ta Cheng  1 , Tang-Wei Chuang  1 , Hsu-Ju Kao  1 , Yu-Hsun Wu  1 , Mai-Gio Pang  1 , Cheng-Heng Lin  1 , Chia-Yi Hou  3 , Hsin-Hua Tsai  4 , Li-Ching Wu  4   5 , Chuan Lee  6
Affiliations

Hepatitis C Virus Subtypes Novel 6g-Related Subtype and 6w Could Be Indigenous in Southern Taiwan with Characteristic Geographic Distribution

Hung-Da Tung et al. Viruses. .

Abstract

Hepatitis C virus (HCV) genotype (GT) 6 is the most genetically diverse GT and mainly distributed in Southeast Asia and south China but not Taiwan. Earlier studies showed the major HCV GTs in Taiwan were GT 1b and 2 with very rare GT 6 except in injection drug users (IDUs), and subtype 6a is the main GT 6 subtype among IDUs. Recently, we reported a much higher prevalence (18.3%) of GT 6 in Tainan City, southern Taiwan. This study was designed to clarify the subtypes of GT 6 in this endemic area. A total of 3022 (1343 men and 1679 women) HCV viremic patients were enrolled. Subtypes of GT 6 were determined by sequencing of core/E1 and nonstructural protein 5B in 322 of 518 GT 6 patients. The overall GT 6 prevalence rate was 17.1% (518/3022), with higher prevalence districts (>25%) located in northern Tainan. A novel 6g-related subtype is the most prevalent subtype (81.0%), followed by 6w (10.8%), 6a (7.5%), and 6n (0.7%). The high GT 6 prevalence in Tainan was mainly due to a novel 6g-related subtype and 6w. These two subtypes could be indigenous in Tainan with characteristic geographic distribution.

Keywords: genotype; hepatitis C virus; injection drug user; phylogenetic analysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Prevalence rates of HCV GT 6 in each district of Tainan. (Blue lines: two main rivers, top: Jishui; middle: Zengwen; red hollow circle, triangle and square: locations of three campuses).
Figure 2
Figure 2
Percentages and numbers of major HCV GT 6 subtypes in Tainan.
Figure 3
Figure 3
Percentages of age distribution of HCV GT 6 subtypes. ID, indeterminate.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Childs K., Davis C., Cannon M., Montague S., Filipe A., Tong L., Simmonds P., Smith D., Thomson E.C., Dusheiko G., et al. Suboptimal SVR rates in African patients with atypical genotype 1 subtypes: Implications for global elimination of hepatitis C. J. Hepatol. 2019;71:1099–1105. doi: 10.1016/j.jhep.2019.07.025. - DOI - PMC - PubMed
    1. Nguyen D.T., Tran T.T.T., Nghiem N.M., Le P.T., Vo Q.M., Day J., Rahman M., Le H.M. Effectiveness of sofosbuvir based direct-acting antiviral regimens for chronic hepatitis C virus genotype 6 patients: Real-world experience in Vietnam. PLoS ONE. 2020;15:e0233446. doi: 10.1371/journal.pone.0233446. - DOI - PMC - PubMed
    1. Chen J.J., Lee P.L., Chiu H.C., Tung H.D., Chiu Y.C., Cheng P.N. Real-world effectiveness and safety of ledipasvir/sofosbuvir for genotype 6 chronic hepatitis C patients in Taiwan. J. Gastroenterol. Hepatol. 2020;35:467–472. doi: 10.1111/jgh.14845. - DOI - PubMed
    1. Mettikanont P., Bunchorntavakul C., Reddy K.R. Systematic review: Epidemiology and response to direct-acting antiviral therapy in genotype 6 chronic hepatitis C virus infection. Aliment. Pharmacol. Ther. 2019;49:492–505. doi: 10.1111/apt.15100. - DOI - PubMed
    1. Smith D.B., Davidson F., Simmonds P. Hepatitis C virus variants and the role of genotyping. J. Hepatol. 1995;23(Suppl. 2):26–31. - PubMed

Substances